Patel H Y, Ormonde S, Brookes N H, Moffatt L S, McGhee C N J
Department of Ophthalmology, Private Bag 92019, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Br J Ophthalmol. 2005 Apr;89(4):404-8. doi: 10.1136/bjo.2004.053116.
To evaluate patient characteristics, indications, surgical details, and outcome of paediatric keratoplasty in New Zealand.
As part of a prospective longitudinal study, paediatric keratoplasty data collected by the New Zealand National Eye Bank (NZNEB) was analysed for the 13 year period 1991-2003.
During the study period the NZNEB supplied 2547 corneas for keratoplasty, of which 65 (3%) were used for paediatric patients (14 years or younger). The 65 keratoplasties were performed in 58 eyes of 52 patients (66% male, 34% female, mean age 10.6 years, SD 4.3 years). Indications were classified into three groups: congenital (16%, n = 9), acquired non-traumatic (74%, n = 43), and acquired traumatic (10%, n = 6). Peters' anomaly (7% of total), keratoconus (67%), and penetrating trauma (8%) were the most common indications in each group, respectively. 82% of keratoplasties with known outcome survived (clear graft) 1 year postoperatively, 16% failed, and one patient died. Keratoplasty for congenital indications had a lower 1 year survival rate (78%) compared to acquired non-traumatic (85%) and traumatic (100%) indications, although the difference was not statistically significant (p = 0.65). 38% of patients with known outcome had a 1 year postoperative best corrected Snellen visual acuity (BCSVA) of 6/9 or better, and 60% had a BCSVA of 6/18 or better. Visual outcome was significantly better for acquired compared to congenital indications (p = 0.03).
Analysis of the NZNEB database provided valuable information in relation to paediatric keratoplasty in New Zealand. In particular, this study highlighted an unusually high prevalence of keratoconus as an indication for keratoplasty. In addition, a high 1 year survival rate and good visual outcome were identified, especially in cases of keratoplasty for acquired conditions.
评估新西兰小儿角膜移植术的患者特征、适应证、手术细节及预后。
作为一项前瞻性纵向研究的一部分,对新西兰国家眼库(NZNEB)在1991年至2003年这13年期间收集的小儿角膜移植数据进行了分析。
在研究期间,NZNEB提供了2547片用于角膜移植的角膜,其中65片(3%)用于小儿患者(14岁及以下)。这65例角膜移植手术在52例患者的58只眼中进行(男性66%,女性34%,平均年龄10.6岁,标准差4.3岁)。适应证分为三组:先天性(16%,n = 9)、后天性非创伤性(74%,n = 43)和后天性创伤性(10%,n = 6)。彼得斯异常(占总数的7%)、圆锥角膜(67%)和穿透性创伤(8%)分别是每组中最常见的适应证。已知预后的角膜移植术中,82%在术后1年存活(植片透明),16%失败,1例患者死亡。先天性适应证的角膜移植术1年存活率(78%)低于后天性非创伤性(85%)和创伤性(100%)适应证,尽管差异无统计学意义(p = 0.65)。已知预后的患者中,38%术后1年最佳矫正视力(BCSVA)为6/9或更好,60%的BCSVA为6/18或更好。后天性适应证的视力预后明显优于先天性适应证(p = 0.03)。
对NZNEB数据库的分析提供了有关新西兰小儿角膜移植术的有价值信息。特别是,本研究突出了圆锥角膜作为角膜移植术适应证的异常高患病率。此外,还确定了较高的1年存活率和良好的视力预后,尤其是在后天性疾病的角膜移植病例中。